Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients.
Klotz LV, Casjens S, Johnen G, Taeger D, Brik A, Eichhorn F, Förster L, Kaiser N, Muley T, Stolp C, Schneider M, Gleichenhagen J, Brüning T, Winter H, Eichhorn M, Weber DG.
Klotz LV, et al. Among authors: forster l.
Lung Cancer. 2024 Jun;192:107802. doi: 10.1016/j.lungcan.2024.107802. Epub 2024 Apr 24.
Lung Cancer. 2024.
PMID: 38692217
Free article.